Olivia Gatliff began their work experience as a Laboratory Assistant at Keregen Therapeutics in September 2016 and ended their role in August 2017. Olivia then joined GSK as a Labs Apprentice in September 2017 and transitioned to the role of Scientist in August 2020. Olivia'stenure at GSK ended in January 2023. Currently, Olivia is working as a Scientist II at Quell Therapeutics, starting in January 2023.
Olivia Gatliff completed their education at the University of Kent, where they obtained a Bachelor's degree in Applied Bioscience from 2020 to 2022. Prior to that, they had completed a Foundation degree in Applied Biosciences from 2017 to 2020, also at the University of Kent.
Links
Sign up to view 0 direct reports
Get started